Bharat Biotech

PM Modi to visit Ahmedabad, Hyderabad and Pune to review COVID-19 vaccine work today

PM Modi to visit Ahmedabad, Hyderabad and Pune to review COVID-19 vaccine work today

Prime Minister Narendra Modi will visit Ahmedabad, Hyderabad and Pune today to review coronavirus vaccine development work at facilities ...Read More

PM Modi to embark on a 3-city visit from tomorrow to review vaccine development

PM Modi to embark on a 3-city visit from tomorrow to review vaccine development

PM Narendra Modi will visit Pune, Ahmedabad and Hyderabad on Saturday to review coronavirus vaccine development work at facilities there.

PM Modi to first visit Pune's Serum Institute, then Hyderabad where Bharat Biotech is developing Covaxin

PM Modi to first visit Pune's Serum Institute, then Hyderabad where Bharat Biotech is developing Covaxin

Mumbai: Days after his meeting with chief ministers on their states' respective preparedness for the distribution of Covid-19 vaccine, Pr...Read More

Coronavirus in India: Phase-3 trial of Bharat Biotech's Covaxin commences in Delhi's AIIMS

Coronavirus in India: Phase-3 trial of Bharat Biotech's Covaxin commences in Delhi's AIIMS

New Delhi: The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS h...Read More

From Pfizer to Oxford: How effective are COVID-19 vaccines of top 5 candidates?

From Pfizer to Oxford: How effective are COVID-19 vaccines of top 5 candidates?

With surging COVID-19 cases the world is now waiting for a vaccine to stop the spread of the disease which has killed millions worldwide....Read More

Covaxin is 60% effective: Bharat Biotech

Covaxin is 60% effective: Bharat Biotech

HYDERABAD: A billion hopes may be riding on Bharat Biotech’s COVID-19 vaccine, but the statement put out by the top contender on Sunday s...Read More

Covaxin will be at least 60% effective, higher than WHO criteria, says Bharat Biotech

Covaxin will be at least 60% effective, higher than WHO criteria, says Bharat Biotech

Five vaccines are under different phases of clinical trials in India.

Race for COVID-19 vaccine: Here is the latest development on Pfizer, Moderna, Bharat Biotech vaccines

Race for COVID-19 vaccine: Here is the latest development on Pfizer, Moderna, Bharat Biotech vaccines

As the worldwide search for a vaccine to treat the coronavirus disease continues, the number of overall global COVID-19 cases has topped ...Read More

Working on a single-dose nasal drop Covid vaccine as well: Bharat Biotech

Working on a single-dose nasal drop Covid vaccine as well: Bharat Biotech

Bharat Biotech raised the logistical query on "how to vaccinate 1.3 billion (130 crore) people with two injectable doses.

Coronavirus in Mumbai: Bharat Biotech's Covaxin to begin trials at Sion Hospital

Coronavirus in Mumbai: Bharat Biotech's Covaxin to begin trials at Sion Hospital

Trials for the indigenous vaccine candidate, 'Covaxin’, manufactured by Bharat Biotech will soon begin at the Lokmanya Tilak Municipal Ge...Read More

COVID-19 Vaccine: Bharat Biotech plans 'Covaxin' launch by June 2021

COVID-19 Vaccine: Bharat Biotech plans 'Covaxin' launch by June 2021

Bharat Biotech, which has received approval to conduct phase 3 clinical trials of its indigenously developed COVID-19 vaccine, has set a ...Read More

COVID-19 vaccine: Bharat Biotech to conduct Phase-3 trials on 26,000 volunteers in 25 centres

COVID-19 vaccine: Bharat Biotech to conduct Phase-3 trials on 26,000 volunteers in 25 centres

Hyderabad: Bharat Biotech, which is into developing Covaxin, a vaccine candidate for COVID-19, on Friday said it has successfully complet...Read More

FPJ Explains: What is intranasal vaccine, being developed by Serum Institute, Bharat Biotech for COVID-19?

FPJ Explains: What is intranasal vaccine, being developed by Serum Institute, Bharat Biotech for COVID-19?

As COVID-19 cases continue to rise in India, Union Health Minister Dr Harsh Vardhan on Sunday noted that while there were no intranasal v...Read More

Submit previous trial data for Covaxin before rolling out phase III: DCGI to Bharat Biotech

Submit previous trial data for Covaxin before rolling out phase III: DCGI to Bharat Biotech

New Delhi: Bharat Biotech, which had sought DCGI's nod for conducting phase-3 clinical trials of its COVID-19 vaccine candidate, has been...Read More

COVID-19 vaccine update: COVAXIN's animal trial gets robust immune responses, says Bharat Biotech

COVID-19 vaccine update: COVAXIN's animal trial gets robust immune responses, says Bharat Biotech

Hyderabad-based Bharat Biotech announced that its potential COVID-19 vaccine, Covaxin, has shown positive efficacy in animal studies and ...Read More

COVID-19 Vaccine Update: Bharat Biotech gets Centre's nod to start phase 2 trials of Covaxin

COVID-19 Vaccine Update: Bharat Biotech gets Centre's nod to start phase 2 trials of Covaxin

Hyderabad-based Bharat Biotech is all set to conduct phase II clinical trials of coronavirus vaccine Covaxin from Monday. Bharat Biotech ...Read More

Latest Coronavirus vaccine update: Bharat Biotech says first round of clinical trials for Covaxin are 'succesful'

Latest Coronavirus vaccine update: Bharat Biotech says first round of clinical trials for Covaxin are 'succesful'

It has been revealed that Covaxin, the vaccine being developed by Bharat Biotech, with the aid of Indian Council of Medical Research to b...Read More

Fact Check: Will Bharat Biotech launch its COVID-19 vaccine COVAXIN on August 15?

Fact Check: Will Bharat Biotech launch its COVID-19 vaccine COVAXIN on August 15?

A letter from the Indian Council of Medical Research (ICMR) claiming to launch the first indigenous COVID-19 vaccine is doing the rounds ...Read More

Latest coronavirus vaccine update: TMC's Mahua Moitra takes jibe at Centre; says vaccine deadline to 'spice up PM Modi's speech'

TMC's Mahua Moitra takes jibe at Centre; says vaccine deadline to 'spice up PM Modi's speech'

TMC leader Mahua Moitra on Sunday night criticized the Centre and the ICMR over the release of COVAXIN – the vaccine developed by Bharat ...Read More

Amid talks of Bharat Biotech to roll out Covaxin, ex-ICMR chief NK Ganguly says 'it takes 18 months to develop good vaccine'

Amid talks of Bharat Biotech to roll out Covaxin, ex-ICMR chief NK Ganguly says 'it takes 18 months to develop good vaccine'

A good vaccine usually takes at least 18 months, before it could be rolled out for production after fast-tracking all the mandatory regul...Read More

Free Press Journal

www.freepressjournal.in